The molecular diagnostic laboratory provides quantitative polymerase chain reaction (PCR), mutation analysis and gene sequencing to support therapy selection, treatment monitoring and minimal residual disease detection with a complete range of clinically actionable tests; Provided as part of MPLN's evidence based comprehensive strategic reflex testing protocol or can be ordered individually. Molecular Diagnostics Flyer (DEC2018)

Molecular Diagnostics Tests

A-Z Molecular Diagnostic Oncology Tests

ABL Kinase Gene Mutation Analysis; Gleevec® Resistance*

AML Mutation Analysis Panel

B-cell IGH Gene Rearrangement by Next Generation Sequencing

BCR/ABL qRT PCR, Major p210 and Minor p190 Mutations, Minimal Residual Disease

BCR/ABL1 t(9;22) by FISH

BRAF Mutation Analysis by Next Generation Sequencing

CEBPA Mutation Analysis*

Chlamydia Trachomatis (CT), Qualitative by Aptima COMBO® 2 TMA

Colon Cancer Panel by Next Generation Sequencing

EGFR Mutation Analysis by Next Generation Sequencing

FLT3 Mutation Analysis*

Herpes Simplex Virus (HSV) Type 1 and 2 Qualitative by PCR

Human Papillomavirus (HPV) Genotyping

Human Papillomavirus (HPV) High Risk by Aptima HPV

IgVH Somatic Hypermutation by Next Generation Sequencing

JAK2 V617F Mutation Analysis by PCR

KIT (D816V) Mutation*

KIT Mutations in AML

KRAS Mutation Analysis by Next Generation Sequencing

← prev 1 2 next →